Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment

Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disease with a significant impact on patients' quality of life and a high socioeconomic burden. And the understanding of IBS has changed since the release of the Rome IV diagnosis in 2016. With the upcoming Rome V revision, it is necessary to review the results of IBS research in recent years. In this review of IBS, we can highlight future concerns by reviewing the results of IBS research on epidemiology, overlap disorders, pathophysiology, and treatment over the past decade and summarizing the latest research.

Automated summary

In the past decade, research on irritable bowel syndrome (IBS) has focused on the results of epidemiology, overlap disorders, pathophysiology, and treatment. With the upcoming release of Rome V revision, it is necessary to review recent research results on IBS in order to highlight future concerns.